• 1. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 2. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 3. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 4. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 5. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Flavonoids 7-hydroxyflavonoids
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Flavonoids Hydroxyflavonoids 7-hydroxyflavonoids

Introduction to Aurantinidin Chloride (CAS No. 25041-66-1)

Aurantinidin Chloride, a compound with the chemical name Aurantinidin Chloride, is a significant molecule in the field of chemical and biomedical research. Its unique chemical structure and properties make it a subject of extensive study in various scientific domains. This introduction delves into the compound's characteristics, its applications, and the latest research findings that highlight its potential in pharmaceutical and biotechnological advancements.

The molecular formula of Aurantinidin Chloride (CAS No. 25041-66-1) is a critical aspect that defines its reactivity and interaction with biological systems. The compound's chemical composition, which includes specific functional groups, influences its behavior in both synthetic chemistry and biological environments. Understanding these structural nuances is essential for harnessing its potential in drug development and therapeutic applications.

In recent years, Aurantinidin Chloride has garnered attention due to its promising role in biomedical research. Studies have indicated that this compound exhibits remarkable properties that could be beneficial in the development of novel therapeutic agents. Its interaction with biological targets and its ability to modulate cellular processes have been areas of intense investigation.

One of the most compelling aspects of Aurantinidin Chloride is its potential in the field of anti-inflammatory and immunomodulatory therapies. Research has shown that this compound can interact with various inflammatory pathways, potentially reducing inflammation and modulating immune responses. These findings are particularly relevant in the context of chronic inflammatory diseases where effective modulation of immune responses is crucial.

The pharmacological profile of Aurantinidin Chloride has been extensively studied in preclinical models. These studies have revealed that the compound can exhibit significant therapeutic effects without causing notable side effects. This makes it an attractive candidate for further development into a therapeutic drug. The compound's ability to target specific pathways while maintaining safety is a key factor in its potential as a drug candidate.

Recent advancements in synthetic chemistry have enabled more efficient synthesis of Aurantinidin Chloride, making it more accessible for research purposes. These improvements in synthesis have not only reduced costs but also enhanced the purity and yield of the compound, facilitating more robust and reliable experimental outcomes.

The application of computational methods has also played a crucial role in understanding the behavior of Aurantinidin Chloride. Molecular modeling and simulations have provided insights into its interactions with biological targets, helping researchers design more effective derivatives with enhanced therapeutic potential.

In conclusion, Aurantinidin Chloride (CAS No. 25041-66-1) is a compound with significant potential in biomedical research and drug development. Its unique chemical properties, along with its promising pharmacological effects, make it a valuable asset in the quest for novel therapeutic agents. As research continues to uncover new applications and mechanisms of action, the future looks bright for this remarkable compound.

• 13306-05-3(Cyanidin)
• 42529-06-6(1-Benzopyrylium,2-(3,4-dihydroxyphenyl)-3,5,6,7-tetrahydroxy-, chloride (9CI))
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)